RyR1 Structural Alterations Explain Statin-Associated Muscle Dysfunction
December 16, 2025
Brand Name :
Ryzumvi (formerly called Nyxol)
Synonyms :
phentolamine ophthalmic
Class :
Miotics, Direct Acting
Dosage Forms & Strengths
eye drop
0.75%
FDA Approval Pending for reversal of pharmacologically induced mydriasis produced by adrenergic agonist or parasympatholytic agents.
Put 1 or 2 drops in each dilated eye after completion of the ophthalmic examination
If 2 drops putted, then the second drop should be administered 5 minutes after the first drop
Dosage Forms & Strengths
eye drop
0.75%
for 3 to 11 years old:
Put 1 drop in each dilated eye after completion of the ophthalmic examination
for >12 years old:
Put 1 or 2 drops in each dilated eye after completion of the ophthalmic examination
If 2 drops putted, then the second drop should be administered 5 minutes after the first drop
Refer to adult dosingÂ
Actions and Spectrum Â
phentolamine ophthalmic acts by blocking the alpha-adrenergic receptors and that to alpha-1 receptors.Â
None
Black Box Warning:Â
NoneÂ
Contraindication/Caution:Â Â Â
None Â
Pregnancy consideration:    Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.
Pharmacology Â
Non-selective alpha-adrenergic antagonist that prevents the smooth muscle of the iris from contracting. Â
Norepinephrine and other catecholamines, which normally bind to these receptors, are inhibited by phentolamine ophthalmic.Â
PharmacodynamicsÂ
phentolamine ophthalmic solution exerts its pharmacodynamic effects locally in the eye. Â
PharmacokineticsÂ
Limited information available on ADMEÂ Â
Administration Â
phentolamine ophthalmic solution is typically administered as eye drops. Â
Patient information leafletÂ
Generic Name: phentolamine ophthalmic
Why do we use phentolamine ophthalmic?Â
Ryzumvi (phentolamine ophthalmic) represents an ophthalmic formulation that functions as a nonselective alpha-adrenergic antagonist. It is currently in the developmental stages for the purpose of reversing pharmacologically induced mydriasis. After completing an eye examination or procedure, Ryzumvi eye drops are administered into each dilated eye to counteract the dilation of the pupils.